Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 38 Neoplasms 33 Depression 28 Fatigue 24 Prostatic Neoplasms 18 Precursor Cell Lymphoblastic Leukemia-Lymphoma 18 Lymphoma, Large B-Cell, Diffuse 17 Lymphoma, Follicular 17 Multiple Myeloma 15 Lymphoma, Non-Hodgkin 14 Lymphoma, Mantle-Cell 14 Leukemia, Lymphocytic, Chronic, B-Cell 14 Burkitt Lymphoma 14 Lymphoma, B-Cell, Marginal Zone 13 Leukemia, Myeloid, Acute 13 Hodgkin Disease 13 Colorectal Neoplasms 13 Lymphoma, Large-Cell, Immunoblastic 12 Lung Neoplasms 12 Anxiety Disorders 12 Lymphoma 11 Leukemia, Myeloid, Chronic-Phase 11 Blast Crisis 11 Leukemia, Myeloid, Accelerated Phase 10 Recurrence 9 Pain 9 Lymphoma, T-Cell, Cutaneous 9 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 9 Leukemia, Hairy Cell 9 Leukemia 9

Interventions

HhAntag691 14 Biopsy 8 Imiquimod 7 Aminolevulinic Acid 7 sonidegib 6 Tomography, Optical Coherence 6 Surgical Procedures, Operative 6 Photochemotherapy 6 Mohs Surgery 6 1-phenyl-3,3-dimethyltriazene 6 Radiotherapy 5 Itraconazole 5 Nivolumab 4 Microscopy, Confocal 4 Curettage 4 pembrolizumab 3 methyl 5-aminolevulinate 3 cemiplimab 3 Standard of Care 3 Niacinamide 3 tazarotene 2 relatlimab 2 X-Rays 2 Watchful Waiting 2 Specimen Handling 2 Observation 2 Magnetic Resonance Spectroscopy 2 Laser Therapy 2 Gene Expression Profiling 2 Eflornithine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma, Basal Cell × Therapeutics × Clear all

NCT03610022 2026-05-19

OPTIVISMO-1

University Hospital, Bordeaux

Phase 4 Completed

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡